VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive impactful life science innovation.
Click Here to download The Mid-Year Update or view it below.
To learn more, visit victech.com
